[1] World Health Organization. The end TB strategy. Geneva: WHO; 2014. https://www.who.int/tb/strategy/en/.
[2] Wang LX, Zhang H, Ruan YZ, Chin DP, Xia YY, Cheng SM, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet 2014;383(9934):2057 − 64. https://www.sciencedirect.com/science/article/abs/pii/S0140673613626392.
[3] Li XW, Yang Y, Liu JM, Zhou F, Cui W, Guan L, et al. Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis. Front Med 2013;7(3):354 − 66. http://dx.doi.org/10.1007/s11684-013-0257-3.
[4] World Health Organization. Global tuberculosis report 2020. Geneva, Switzerland: WHO; 2020. https://apps.who.int/iris/handle/10665/336069.
[5] Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 2016;13(10):e1002152. http://dx.doi.org/10.1371/journal.pmed.1002152.
[6] Shanghai Municipal Health Commission. Epidemic situation of notifiable infectious diseases in Shanghai in 2019. Shanghai; 2020. http://wsjkw.sh.gov.cn/yqxx/20200703/ce47739b555e4b70bea9f704678524ee.html. (In Chinese).
[7] Cui XJ, Gao L, Cao B. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries. Int J Infect Dis 2020;92 Suppl:S37 − 40. http://dx.doi.org/10.1016/j.ijid.2020.02.034.
[8] Gao L, Zhou F, Li XW, Jin Q. HIV/TB co-infection in mainland China: a meta-analysis. PLoS One 2010;5(5):e10736. http://dx.doi.org/10.1371/journal.pone.0010736.
[9] Tobe RG, Xu LZ, Song PP, Huang Y. The rural-to-urban migrant population in China: gloomy prospects for tuberculosis control. Biosci Trends 2011;5(6):226 − 30. http://dx.doi.org/10.5582/bst.2011.v5.6.226.
[10] Cao SY, Gan Y, Wang C, Bachmann M, Wei SB, Gong J, et al. Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Nat Commun 2020;11(1):5917. http://dx.doi.org/10.1038/s41467-020-19802-w.